Investment
Features
FeesSafety
Academy
More
Pluang+

Pi Network price dips below $0.09 amid weak trading and awaits key Protocol 28 upgrade.

Technical Signals
06 Oct 2026
Crypto news
View Source
Bearish
Pi Network price dips below $0.09 amid weak trading and awaits key Protocol 28 upgrade.

Pi Network's price has fallen to around $0.087 after failing to sustain gains near $0.0935 last week. The token remains below key moving averages, indicating bearish momentum, and trading volume has declined by about 34%, showing weak market participation. A major network upgrade, Protocol 28, is scheduled with a node update deadline on October 13 and mainnet launch on October 16, but this has yet to boost the price. Analyst forecasts suggest a potential bullish breakout above $0.11 could lead to targets near $0.14, but the current trend remains cautious as the price struggles to hold support levels.

Pi Network price movement is the subject, with Pluang's market data providing context. For readers following major cryptocurrencies, 24 out of 50 rose and 25 fell today. Notable movers include ADA at Rp4.871 with a 2.98% gain and CRV at Rp6.503 down 2.87%, as of Oct 07, 2026 00:03 WIB.

More News

Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlook

Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlook

Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...

Market News
Neutral
1 hour ago
Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
1 hour ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
2 hours ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
2 hours ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App